AdvisorShares Investments’s Ascendis Pharma A/S ASND Stock Holding History

AdvisorShares Investments’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.33M	Sell	4,982 -768	-13%	-$179K	0.16%	68
2026 Q1	$1.32M	Buy	5,750 +34	+0.6%	+$7.62K	0.24%	61
2025 Q4	$1.22M	Buy	5,716 +158	+3%	+$32.6K	0.2%	65
2025 Q3	$1.1M	Sell	5,558 -960	-15%	-$179K	0.18%	65
2025 Q2	$1.13M	Buy	+6,518	New	+$1.06M	0.2%	63

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

AdvisorShares Investments's ASND Position: Q2 2026 in Review

AdvisorShares Investments reduced its Ascendis Pharma A/S (ASND) stake by 13% in Q2 2026, selling an estimated $179K and leaving 4,982 shares worth $1.33M. The position accounts for 0.16% of the portfolio, ranked #68.

AdvisorShares Investments first reported a position in ASND in Q2 2025 and has held it in 5 quarters since. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

AdvisorShares Investments held 4,982 shares of Ascendis Pharma A/S worth $1.33M as of Q2 2026.
AdvisorShares Investments sold 768 Ascendis Pharma A/S shares in Q2 2026, an estimated $179K.
Ascendis Pharma A/S made up 0.16% of AdvisorShares Investments's portfolio in Q2 2026, its #68 holding.
AdvisorShares Investments first reported a position in Ascendis Pharma A/S in Q2 2025 and has held it in 5 quarters since.
313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on AdvisorShares Investments's 13F filing for Q2 2026, filed 11 Aug 2026.